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INTRODUCTION: MEDICAL AND LEGAL ADVANCES
IN FERTILITY PRESERVATION
Brittany Ann Heitz*

Medical advancements in the field of fertility preservation increase
the reproductive options available to patients worldwide. In its most
recent report on assisted reproductive technologies (ART), the Centers for Disease Control and Prevention (CDC) found that 2%, or 1.2
million, of the 62 million American women of childbearing age had
made an appointment for infertility services in 2002.1 It also found
that ten percent of this same group received such services at some
point in their lives. 2 As the number of persons affected by fertility
increases, related legal issues arise with increasing frequency.
Fertility treatment often implicates numerous legal rights, such as
the right to privacy, the right to equal protection, and the right to due
process. Cutting-edge medical technologies are constantly evolving
and raise new social, economic, political, and legal issues. The law
must adapt to account for the intersection of these rights and issues,
yet it remains a few steps behind.
The Twenty-first Annual DePaul Law Review Symposium examined the medical advancements in fertility preservation and their
legal and social implications. The Symposium took a multidisciplinary
approach to the topic, drawing upon the experiences of medical researchers who focus on ART and legal scholars and practitioners who
explore their legal implications, as well as doctors who perform fertility preservation treatments and patients who have underwent them.
After first considering the field of fertility preservation generally, the
Symposium turned its attention to oncofertility, the "interdisciplinary
* Symposium Editor, DePaul Law Review, Volume 60; J.D. 2011, DePaul University College
of Law; B.S. 2008, University of Illinois Urbana-Champaign. The author is an associate in the
Chicago office of Schiller DuCanto & Fleck LLP, the nation's largest family law firm, where she
uses her passion for the law and her background studying families to zealously advocate for her
clients and counsel them through an emotional and trying time in their lives.
1.

CDC, ASSISTED REPRODUCTIVE TECHNOLOGY SUCCEss RATES: NATIONAL SUMMARY AND

FERTILITY CLINIC REPORT 3 (2009), available at http://www.cdc.gov/art/ART2009/PDF/ART

2009_Full.pdf (reporting on data from the 2002 National Survey of Family Growth).
2. Id.
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field at the intersection of oncology and reproductive medicine that
expands fertility options for cancer survivors." 3
The Symposium opened with a presentation from Dr. Ina Cholst, an
associate professor of obstetrics and gynecology and reproductive
medicine at Weill Cornell Medical College. Dr. Cholst focuses her
practice on the ethical and psychological issues arising from the use of
egg donation. Her presentation laid the groundwork for the later
presenters, and without her contributions we, as an audience, would
not have been able to fully understand the issues at hand.
Dr. Cholst began by providing an overview of the various fertility
preservation treatments, outlining the different options available to
women and men, and adults and children. In doing so, she noted that
many persons seeking fertility preservation treatment are individuals
with benign diseases, females whose ovaries need removing, persons
with genetic illnesses, or persons diagnosed with cancer. She then discussed more-common fertility preservation options, such as embryo
freezing, detailing the many issues that these individuals may face in
seeking treatment. Dr. Cholst also discussed more experimental techniques, such as the cryopreservation of ovarian tissue, which may
eventually be used to preserve the future fertility options of children.
Dr. Cholst concluded by exploring the social and cultural implications
of using fertility preservation treatments with children.
Dr. Cholst's contribution to this Symposium Issue, entitled
Oncofertility: Preservationof Reproductive Potential,4 builds on these

points. Her article articulates the different treatment options available and connects these options to social and cultural issues. For example, Dr. Cholst notes the disparity in fertility preservation options
between men and women. Her article also emphasizes the role of
medical practitioners in the fertility preservation process, especially in
the context of oncofertility, and advises doctors to take care not to
harm the body more than necessary and approach patients with an
understanding of what lies ahead.
The next presenter was Professor Nanette Elster, former director of
the Health Law Institute at DePaul University College of Law. Professor Elster teaches numerous classes on reproduction, genetics, and
3. About the Oncofertility Consortium, ONCOFERTILITY CONSORTIUM, http://oncofertility.
northwestern.edu/about-us (last visited May 19, 2012). Teresa Woodruff, director of the
Oncofertility Consortium at Northwestern University, "coined the term oncofertility to describe
a new discipline that bridges oncology and reproductive medicine in order to discover and apply
new fertility preservation options for young patients with fertility-threatening diseases or treatments." Id.
4. See Ina N. Cholst, Oncofertility: Preservationof Reproductive Potential,61 DEPAUL L. REV.
763 (2012).
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ethics, and she is also the Vice President of Spence & Elster, P.C., a
Chicago-area law firm that focuses on fertility law. Professor Elster
used her extensive experience and expertise to provide the audience
with a general understanding of the legal issues surrounding the advances in fertility preservation including, most importantly, informed
consent.
The field of fertility preservation borrows its concept of informed
consent from the area of medical malpractice, established in the seminal case of Canterbury v. Spence, and requires that consent be knowing, informed, and voluntary.5 Professor Elster emphasized that when
working with persons still deciding whether to undergo fertility treatments, especially those dealing with cancer and other medical conditions, obtaining informed consent from the patient should require an
ongoing dialogue. She urged that these conversations include lawyers,
doctors, clergymen, ethicists, and psychologists, who should discuss
the impact of undergoing fertility treatments, their associated costs
and potential success rates, and whether other treatments may compromise the patient's fertility. For previvors, defined as persons who
have not yet been diagnosed with cancer but have a predisposition to
cancer, 6 the discussion should also include geneticists to better understand how their condition may affect their offspring. Although little
legal guidance exists regarding fertility preservation, the discussions
must be thorough and are a necessary step prior to undergoing any
treatment.
After providing this general overview, Professor Elster then highlighted the complex legal issues arising from freezing children's embryos for future use. Given the scarce legal guidance in this area of
the law, many questions remain unanswered. Being aware of potential legal issues is the first step in combatting them as they arise in the
future, and Professor Elster's presentation provided the necessary guidance to do so.
The latter half of the Symposium dealt primarily with oncofertility.
To contextualize the subject, a panel of medical researchers provided
unique and diverse perspectives. Dr. Lisa Campo-Engelstein, a postdoctoral fellow with the Department of Medical Humanities &
Bioethics at Northwestern University Feinberg School of Medicine,
discussed the issue of insurance coverage for conditions induced by
cancer treatment, comparing fertility preservation to reconstructive
surgery following breast cancer. Dr. Campo-Engelstein fully explores
5. 464 F.2d 772 (D.C. Cir. 1972).
6. Cancer Previvors, FORCE, http://www.facingourrisk.org/info-research/previvors-survivors/
cancer-previvors/index.php (last visited May 19, 2012).
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this topic in her submission to this Issue, entitled Insurance Coverage
for Cancer Treatment-Induced Conditions: Comparing Fertility Preservation Technology and Breast Reconstructive Surgery.7

In both her presentation and her commentary, Dr. Campo-Engelstein focuses on handling fertility preservation treatment in practice.
She highlights the impact that subtle decisions made by medical practitioners and insurers have on patients.8 Dr. Campo-Engelstein's
analysis provides a practical analysis of what patients face when determining whether to undergo these types of treatments.
Next, Dr. Patricia Hershberger, an assistant professor of nursing
and affiliate professor of medicine at the University of Illinois at Chicago, spoke about young women diagnosed with cancer and their
decision-making processes regarding fertility preservation. Dr. Hershberger further explored the concept of informed consent described by
Professor Elster earlier in the day. She provided quotes and stories
from young women deciding whether to undergo fertility preservation. Her presentation highlighted the gravity of their mental and
emotional states before, during, and after making such decisions.
To conclude the oncofertility panel's discussion, Dr. Sarah Rodriguez, a postdoctoral fellow in the Department of Medical Humanities
& Bioethics at Northwestern University Feinberg School of Medicine,
examined conception and cancer from a historical perspective. Dr.
Rodriguez focused her discussion on the biomedical model of cancer
and the tendency of practitioners to devote their efforts solely to
treatment options for cancer, rather than preventative solutions. She
then linked this biomedical model and solution-based approach to the
increased awareness of the potential infertility of children and young
adults. Dr. Rodriguez also provides a written conclusion to this Issue,

entitled Cancer, Infertility, and the Narrative of Progress.9 Her com-

mentary challenges readers to reconsider the attention given to cancer
treatment and advocates instead for a preventative approach.
The Symposium's keynote speaker was Professor Dorothy Roberts,
a Kirkland & Ellis Professor at Northwestern University School of
Law. Professor Roberts has written and lectured extensively on the
interplay of gender, race, and class in legal issues concerning repro7. Lisa Campo-Engelstein, Insurance Coverage for Cancer Treatment-Induced Conditions:
Comparing Fertility Preservation Technology and Breast Reconstructive Surgery, 61 DEPAUL L.
REV. 849 (2012).

8. For example, the difference between coding a treatment as a cancer treatment rather than
procreative management. Id. at 854.
9. Sarah Rodriguez, Cancer,Infertility, and the Narrative of Progress,61 DEPAUL L. REV. 861
(2012).
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duction, bioethics, and child welfare. Professor Roberts utilized the
unique socioeconomic perspective she has cultivated in her awardwinning books and articles to discuss the social, economic, and political context of fertility preservation. Her presentation directed the audience to analyze the societal effect of fertility preservation and
childbearing.
Professor Roberts's thought-provoking contribution to this Issue,
entitled The Social Context of Oncofertility,1 0 focuses on three societal

inequalities that may result from fertility preservation: gender inequality, economic inequality, and racial inequality. With respect to
gender inequality, her article questions whether fertility preservation
reinforces gender norms by fulfilling the expectation that women will
reproduce, or whether it simply expands women's choices in making
decisions regarding childbearing in the future. With respect to economic inequality, Professor Roberts highlights the sometimesprohibitive cost of using fertility preservation methods. Finally, with
respect to racial inequality, she analyzes whether ART permits
women to have children who are genetically related to them. She argues that these technologies emphasize society's preference for genetic relatedness over adoption when choosing how to become
parents. Professor Roberts's contribution to the Symposium and this
Issue asks listeners and readers to think critically about the societal
implications of fertility preservation, and she made the event a tremendous success.
The final panel of speakers at the Symposium rounded out the day
by providing a "patient's perspective." Kristin Smith, a patient navigator at Northwestern Memorial Hospital, discussed her experiences
working with patients who are either currently undergoing or deciding
whether to undergo fertility preservation. Joining her were two of her
patients who underwent fertility preservation treatment, Bonnie
Goldsborough and Holly Manprisio. The panel offered the most intimate contribution of the day and provided a personal touch to the
Symposium's legal, medical, and ethical dilemmas. The practitioners,
doctors, lawyers, and scholars in attendance were able to hear firsthand the stories of two individuals who underwent such invasive and
overwhelming treatments. Their willingness to share such personal
experiences is something for which we cannot thank them enough.
The day simply would not have been the same without them.
This Issue also contains an article by an author who did not present
at the Symposium, Be Fruitful and Multiply, by Other Means, if Neces10. Dorothy E. Roberts, The Social Context of Oncofertility, 61
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sary: The Time Has Come to Recognize and Enforce Gestational Sur-

rogacy Agreements by Paul G. Arshagouni. 1 1 Professor Arshagouni
sets his sights on gestational surrogacy, yet another issue raised by the
ever-advancing reproductive options available to those unable or unwilling to conceive a child through traditional means. In his article, he
argues that gestational surrogacy is not necessarily the deleterious
practice that critics contend and that such contracts should be valid
and enforceable. Underscoring the importance of this issue and the
myriad implications flowing from the medical advancements in fertility preservation is a comment authored by Law Review member Chelsea VanWormer, who advocates for amending Michigan's gestational
surrogacy law to recognize and regulate gestational surrogacy
contracts. 12
Finally, I would be remiss if I did not give a special thank you to the
many people without whom the Symposium and this Issue would not
have occurred. First, Nanette Elster was an invaluable mentor
throughout this entire process. She provided guidance, innovative
ideas, and mentorship throughout the every stage of planning this
Symposium. Her teaching personality and dedication to this field of
law gave me the foundation needed to create such a great event.
Thank you also to all of the speakers at the Symposium, as well as the
authors in this Issue, for taking time out of their busy schedules to
make both the Symposium and this Issue such a great success. Also, I
am so grateful for the Volume 60 Editorial Board's suggestions, support, patience, and willingness to help. Thank you to the Volume 60
staff members who provided extra sets of hands on the day of the
Symposium. And last, but certainly not least, thank you to the Volume 61 Editorial Board for their tireless efforts in publishing this Issue. Their contributions have memorialized the topics of discussion
from this Symposium for future debate as emerging issues continue to
arise.

11. Paul G. Arshagouni, Be Fruitful and Multiply, by Other Means, if Necessary: The Time
Has Come to Recognize and Enforce GestationalSurrogacy Agreements, 61 DEPAUL L. REV. 799
(2012).
12. Chelsea VanWormter, Outdated and Ineffective: An Analysis of Michigan's GestationalSurrogacy Law and the Need for Validation of Surrogate Pregnancy Contracts, 61 DEPAUL L. REV.
911 (2012).

